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Prorenin activation and prohormone convertases in the mouse As4.1
cell line. The precise identification of prorenin-processing enzymes has
been hampered by the very low abundance of juxtaglomerular cells in the
kidney. Recently, an immortalized renin-producing renal tumor cell line
(As4.1) has been proposed as a model to carty out such studies. Depite the
fact that they contain secretory granules, we found no evidence (on the
basis of enzymatic assays of renin activity in the supernatant of the cells
and of immunoprecipitations experiments) that the As4.l cells can secrete
active renin through the regulated pathway. As4.l cells produce only
renin-l, as they derive from a strain of mice expressing only one renin
gene. However, stable transfection of these cells with a renin-2 expression
plasmid increased the capacity of this cell line to secrete active renin in the
regulated pathway. Northern blot and reverse transcriptase-polymerase
chain reaction amplification (RT-PCR) assays revealed that furin, PACE4
and PC5 were the only members of the proprotein convertase (PC) family
to be present in these cells. As PC5 is the only such enzyme with the
demonstrated ability to process mouse prorenin 2, it may constitute a
candidate enzyme for the processing of prorenin-2 in mouse juxtaglomer-
ular cells. However, it is not likely to be involved in the processing of
mouse prorenin 1.
The activity of the renin-angiotensin system (RAS) has been
implicated in the pathogenesis of numerous cardiovascular dis-
eases including hypertension (either essential or pregnancy-in-
duced), cardiac hypertrophy and myocardial infarction. Renin, an
aspartyl protease secreted by the kidney, catalyzes the rate-
limiting step in the RAS. Renin, itself, is first synthesized as an
inactive precursor, or zymogen, called prorenin. In humans,
generation of circulating active renin occurs by the proteolytic
removal of a 43 amino acid peptide from the amino terminus of
prorcnin [1, 2 within the dense core secretory granules of the
renal juxtaglomerular (JG) cells. Active rat renin has a different
amino terminus than human renin [3, 4], suggesting that different
proteases may be involved in its generation. In the mouse there
are two main isoforms of renin. While all strains of mice express
the Ren-I gene in the kidney, most mouse strains express another
renin gene (called Ren-2). The Ren-2 gene is expressed primarily
in the submaxillary gland (SMG), so that its protein product is
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often referred to as "SMG renin." However, Ren-2 is also
expressed in kidneys and in other tissues [2]. In particular, the
kidneys of mice expressing both renin genes contain equal
amounts of Ren-I and Ren-2 mRNA [51. While cleavage of SMG
renin occurs at a position analogous to that of human renin
[reviewed in 21, it is not yet known whether the product of the
Ren-1 gene is cleaved like human or rat renal renin.
Several enzymes capable of cleaving mouse SMG renin have
been identified, including PRECE, glandular kallikreins, cathep-
sins and convertases [6—8]. In humans, three particular enzymes
(PCI, PC5 and Cathepsin B) have been proposed as prorenin
processing enzymes (PPEs) [9—11]. Surprisingly, none of the
enzymes identified to date are capable of activating either mouse
Ren-l or rat prorcnin. These results might indicate that different
proteases activate prorenin in different species. Alternatively, the
PPE active in the JG cells of the kidney might not correspond to
any of the proteases identified to date. A severe impediment to
the identification of candidate PPEs in JG cells is the lack of
established JG cells in culture which have retained the differen-
tiated characteristics of the JG apparatus in viva. Recently,
Sigmund et al [12] reported the isolation of an immortalized
renin-secreting cell line (As4.I) from the kidney of mice in which
tumors were targeted to renin-expressing cells by transgenesis.
This cell line is unique in that it is the only established cell line
reported to retain characteristics of differentiated JG cells. In an
effort to identify candidate PPEs in JG cells, we sought to
determine which of the known prohormone processing enzymes
were present in the As4.I cell line, and correlate these data to the
ability of As4.1 cells to process prorenin.
Methods
Cell culture
As4.l cells [12] were grown in a 37°C humidified incubator in
5% CO, 95% air, and maintained in Dulbecco's Modified Eagle's
Medium (DMEM; Gibco BRL, Burlington, ON, Canada) supple-
mented with 10% fetal calf serum (FCS) and 10 .rg/ml gentamicin.
For either secretion or immunoprecipitation experiments, the
cells (between passages 5 and 40) were replated in 24 well dishes
at a density of 1.4 i0 cells/cm2, and used five days after plating.
Enzymatic renin assays
For secretion experiments, cells were washed with phosphate-
buffered saline (PBS), then incubated in DMEM supplemented
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with 5% FCS for various periods of time. The supernatants were
then collected, and prorenin and renin contents were determined
by the angiotensin I (Ang I) generation assay, as described
previously [13]. Briefly, aliquots of supernatant were incubated in
the presence of excess semipurified sheep angiotensinogen, either
directly (active renin content) or after incubation with trypsin to
cleave prorenin into active renin (total renin content = prorerlin
+ renin). Percent renin activity was calculated as: (active renin
content/total renin content) x 100. It was verified that no renin
activity could be detected in the medium prior to incubation on
the cells. The values of renin were expressed as the amounts of
Ang I generated in one hour of incubation. To correct renin
content in the supernant for the number of cells present in each
well, the cells were sonicated in buffer and the amount of DNA
present in the homogenates was determined by ethidium bromide
fluorescence as described previously [14].
Immunopreciitation of renin/prorenin
As4.1 cells were replated in 24 well dishes at a density of 1.4 i0
cells/cm2. Five days after replating, the cells were rinsed twice with
0.5 ml of methionine-free medium (90% methionine-free
DMEM, 10% complete DMEM, 10% dialyzed FCS) and were
incubated for times ranging from 15 minutes to 16 hours in
methionine-free medium containing 300 jiCi [35S] methionine
(600 Ci/mmol; Dupont NEN, Boston, MA, USA). Culture super-
natants were then collected either immediately (overnight label-
ing) or after a further incubation in nonradioactive complete
DMEM for a period of two hours (pulse-chase). After the labeling
period, medium was collected and adjusted to 0.1% sodium
dodecyl sulfate (SDS) and 1% Nonidet P-40 (NP-40), sequen-
tially. Immunoprecipitation was carried out as previously de-
scribed [15] using 5 jil/mI of a goat antiserum raised against
purified mouse SMG renin (strain SWR). This antibody (gift of
Dr. Carol Wilson, Southwestern Medical Center, U. of Texas,
Dallas, TX, USA) also immunoprecipitates mouse Ren-1 and
human prorenin (data not shown).
Both inhibition of endogenous glycosylation (by tunicamycin)
and enzymatic removal of glycosyl residues in immunoprecipi-
tated renin (using endoglycosidase F) were used to determine the
glycosylation state of the renin expressed in As4.1 cells. For
inhibition of glycosylation, the cells were pre-incubated for three
hours prior to labeling in methionine-free medium containing 5
jig/mi tunicamycin and all subsequent labeling steps were carried
out in the presence of tunicamycin. For enzymatic deglysosylation,
protein A sepharose/antibody/renin complexes were re-suspended
in endoF buffer (50 m sodium acetate pH 5.2, 10 ifiM EDTA, 1%
NP-40) and were incubated for 16 to 20 hours at 37°C with 0.1
units of a mixture of endoglycosidase F and N-glycosidase F
(Boehringer Mannheim).
Immunoprecipitates were fractionated by SDS-PAGE using
12% acryiamide and radiolabeled proteins were detected by
fluorography, as described previously [15].
Electron microscopy
As4.1 cells were replated at a density of 7800 cells/cm2 in a 35
mm culture dish. Five days later, the medium was removed, the
cells were rinsed once in phosphate buffered saline (PBS) and
were fixed for one hour at 25°C in cacodylate buffer (0.1 M sodium
cacodylate, pH 7.1) containing 2% glutaraldehyde. The cell
monolayer was post-fixed in 2% osmium tetroxide and embedded
in LXI12 resin (Ladd Research Industries, Burlington, VT, USA)
for electron microscopic observation according to standard meth-
odologies.
Analysis of RNA
Total RNA was isolated from As4.l cells by the guanidinium-
cesium chloride method [16]. Ten micrograms of total RNA was
separated by denaturing agarose gel electrophoresis, transferred
to a nylon membrane and hybridized to antisense {32Pj-labeled
cRNA radiolabeled probes for the various possible convertases, as
previously described [17]. The probes used were the same as
described previously [18], and corresponded to 590 bases of rat
PCI, 425 bases of rat PC2, 1232 bases of rat furin, 390 bases of rat
PC4, 534 bases of rat PACE4 and 837 bases of rat PC5. RNA size
was approximated by comigration of a 0.24 to 9.5 Kb RNA ladder
(Gibco BRL).
Reverse transcriptase polymerase chain reaction amplifications
Reverse transcriptase polymerase chain reaction (RT-PCR)
analysis of RNA samples was performed with the GeneAmp RNA
PCR kit (Perkin Elmer Cetus). Briefly, either 2.5 jig of total RNA
or 1 jig of polyA(+) RNA isolated from As4.1 cells were reverse
transcribed using oligo-dT as a primer and Moloney murine
leukemia virus (M-MLV) reverse transcriptase for 50 minutes at
42°C. The resulting material was heat-denatured for five minutes
at 99°C and PCR-amplified using two degenerate oligonucleotides
representing the consensus sequence based on the alignment of
the convertases catalytic subunits [19]. The sense oligonucleotide
was ATC TAC AG(T,C) GC(A,C) AG(C,T) TGG GGC CC. The
antisense oligonucleotide was CAG (A,G)TG (C,T)TG CAT
GTC (T,C)C(T,G) CCA GGT. PCR amplification was performed
for 35 cycles on a Perkin-Elmer model 9600 turbo PCR cycler,
using a program consisting of 20 seconds at 94°C, one minute at
50°C and one minute at 72°C. The 450 hp reaction products were
purified by agarose and cloned into a PCRII vector. One hundred
ninety-seven different individual clones were isolated in this
manner, and each was analyzed by automatic sequencing, as
described previously [19].
Transfection of As4.J cells with an expression plasmid for mouse
Ren-2
An expression vector was constructed by inserting the coding
sequence of mouse Ren-2 eDNA into the expression plasmid
pCEP4 (In Vitrogen, San Diego, CA, USA), which contains the
CMV promoter and an hygromycine resistance gene. Aliquots of
5 x 106 As4.1 cells were transfected with 20 jig of this plasmid by
electroporation and plated in 35 mm-diameter Petri dishes.
Selection of transfected cells was then performed in the presence
of 20 jig/mI of hygromycin B.
Results
As4. I cells secrete Ren-1 prorenin
Cell culture supernatants from As4.1 cells were assayed for
prorenin and renin by the angiotensin I generation assay. While
the supernatants contained abundant quantities of prorenin, they
contained only very small amounts of renin enzymatic activity
(corresponding to 5% of total renin; Table 1). To test whether
this apparent renin activity could correspond to material released
by renin-containing secretory granules from within As4.I cells, we
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Table 1. Amounts of total renin, inactive prorenin and active renin in
the incubation medium of As4.1 cells
Treatment Total renin Prorenin Active renin % Active renin
Control 4.4 0.5 4.2 0.5 0.22 0.03 5 1
db-cAMP 4.5 0.4 4.2 0.4 0.27 0.02 6 1
After washing, cells were incubated in medium for a total of 2 hours in
the absence (control) or in the presence of I0 M dihutyryl-cyclic AMP
(db-cAMP). Each value corresponds to mean SD (N = 6), and are
expressed as ng Ang I/hr/j.rg DNA.
tested the effect of the secretagogue dibutyryl-cAMP (Table 1).
This treatment did not significantly increase the amount of active
renin in the supernatant of As4.1 cells. Likewise, no effect was
observed when treating the cells with either 10 LM forskolin or 65
mM KCI (data not shown).
To determine whether the trace amounts of renin activity
detected in our enzymatic assay corresponded to bona fide active
renin of the expected molecular weight, As4.1 cells were meta-
bolically labeled and the supernatants of these cultures were
immunoprecipitated with an antiserum to mouse renin (Fig. 1).
Immunoprecipitation of supernatants from As4.1 cells labeled for
15 minutes and subsequently chased for two hours reveals a broad
complex of bands of approximately 44 to 48 kDa. To obtain a
better resolution of the proteins present in this complex, we
treated immunoprecipitated supernatant with a mixture of en-
doglycosidase F and N-glycosidase F. As the first enzyme cleaves
the second bond of asparagine-linked oligosaccharides, and the
second one cleaves the bond between the oligosaccharide and the
asparagine residue, this combination of enzymes has the capability
of cleaving most asparagine-linked oligosaccharides. This enzy-
matic treatment converts the initial broad renin band to a smaller
triplet of bands between 38 and 44 kDa. Treatment of the As4.1
cells with tunicamycin results in the secretion of a single protein
band of 38 kDa molecular weight. Longer labeling periods up to
16 hours in the presence of tunicamicyn failed to reveal any
additional lower molecular weight (< 38 kDa) bands which would
be expected if prorenin had been converted to active renin by
proteolysis (data not shown). Therefore, the major metabolic
product in the incubation medium of As4.1 cells is prorenin.
As4. 1 cells contain dense core secretoly granules
Previous studies have suggested that the proteolytic activation
of prorenin takes place in the dense core secretory granules of JG
cells [201. As4.1 cells have previously been shown to contain such
granules [121, but it was important to verify that the cells in our
hands had not lost this important characteristic. We therefore
performed an electron microscopy analysis, which confirmed that
cytoplasmic dense core secretory granules were indeed present in
all cells observed (Fig. 2), although the abundance of granules per
ccli varied greatly.
Expression of processing enzymes in As4. 1 cells
A Northern blot of As4.1 RNA was hybridized with probes
specific for different members of the prohormone/proprotein
convertase (PC) family of enzymes (Fig. 3). No expression of
either PCI or PC2 was detectable, whereas PC5, furin and
PACE-4 were abundantly expressed in As4.1 cells. To test
whether other, previously uncharacterized but related members of
the PC family might be expressed in these cells, we carried out
RT-PCR using degenerate oligonucleotides derived from con-
served sequences near the active site of this family of enzymes
[191. In analysis of 197 clones, we did not identify any potentially
new sequence for related members of the PC family of proteases
(data not shown). Taken together, these results show that PC5,
furin and PACE-4 are the major proprotein convertases expressed
in the As4.1 cells. Within the limits of the degenerate oligonucle-
otides used here [19], we did not find any evidence that these cells
express a novel convertase related to the PC family.
Active and total renin in the supernatant of As4. 1 cells stably
transfected with an expression plasmid for Ren-2
We compared the active renin secretion ability of As4.1 cells
stably transfected with either pCEP4 (control cells) or pCEP4
containing the mouse Ren-2 eDNA insert (Fig. 4). Basal levels of
active renin were higher in the supernants of cells transfected with
the Ren-2 expression plasmid than in cells transfected with the
control plasmid. Addition of i0— M forskolin did increase the
amount of active renin in the incubation medium of cells trails-
fected with Ren-2 expression plasmid, but not in that of control
cells. The higher levels of active renin did not appear to be an
artifactual consequence of higher secretion of total renin, since
total renin secretion was actually lower in cells transfected with
Ren-2 than in control cells transfected with pCEP4 (Fig. 4).
Likewise, forskolin had no effect on total renin secretion.
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Fig. 1. Immunoprecipitation of labeled prorenin from the incubation me-
dium of 4 s4.I cells. Cells were pulse-labeled with [35S]-methionine for 15
minutes and chased with complete medium for two hours. In the second
lane, the immunoprecipitated material was treated for 18 hours at 37°C
with the mixture of Endoglycosidae F/N-Glycosidase F (Endo F) before
being loaded on the gel. For the third lane, tunicamycin (5 /Lg/ml) was
added to the cells 15 minutes before the pulse, and maintained in the
medium during the pulse and the chase periods.
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Fig. 2. Electron microscopy micrographs of As4. 1 cells. Nuclei are marked with the letter N. Dense core secretory granules are labeled with the letter
g. The Magnifications were x4,500 (left micrograph) and ><3,600 (right micrograph).
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Fig. 3. Northern blot analysis of total RNA from As4. I cells. This is a
composite from five different blots, hybridized to labeled probes for either
PCi, PC2, PC5, furin or PACE4; the letter "r" corresponds to nonspecific
hybridization to ribosomal RNA. Ten micrograms of total RNA were used
in each lane.
Discussion
The primary source of circulating active renin in mammals is
the JG apparatus of the renal cortex. Biochemical characteriza-
tion of the JG cell has been hampered by the lack of sufficient
quantities of these cells. Although it is possible to prepare primary
cultures of JG cells [21], their low abundance in the kidney (0.1%
of the total renal cell mass) makes this approach impractical for
most biochemical techniques. In the current study, we have sought
to characterize the prorenin processing activity in the As4.1 cell
line, which may constitute the only cell line available which retains
(at least some) characteristics of differentiated JG cells [12]. Our
results confirm that these cells express glycosylated forms of
prorenin. However, only low amounts of renin enzymatic activity
were detected in the incubation medium, and treatment of the
cells with agents known to stimulate secretion of products from
the regulated pathway [221 did not increase renin activity in the
supernatants. Furthermore, pulse-chase experiments were re-
peated more than three different times and never detected forms
of renin whose size might be comparable to that expected from
proteolytically activated renin. Altogether, these data provide no
indication that As4.1 cells can secrete any significant amount of
active renin via the regulated pathway. The low amounts of renin
activity detected in the supernatant might be attributed to prore-
nm itself, as this protein can exhibit low levels of basal activity in
the absence of cleavage of the prosegment [13]. Previous studies
had shown that treatment of the cells with 8-bromo-cAMP
increased the amount of renin activity in the supernatant [12].
However, the cAMP analog was applied for times ranging from 4
to 15 hours. It is therefore likely that the previous results are a
consequence of the activation of the expression of the renin gene
rather than the induction of the release of active renin.
Mouse Ren-2 prorenin does not contain potential glycosylation
sites [23]. As4.1 cells do not secrete any unglycosylated amounts
of prorenin, and thus do not appear to produce any Ren-2
prorenin, which is consistent with the fact that the mouse lines
used to derive the As4.1 cells express only the Ren-1 gene [121.
As4.1 cells also appear to have lost the ability to secrete significant
amounts of active renin in the extracellular medium. This could be
due to a number of factors, including the loss of dense core
secretory granules, the loss of expression of the appropriate
prorenin processing enzyme or some other defect in the release of
the active renin from the cells. Loss of secretory granules from
immortalized human reninoma cell line has been reported and
correlates with the loss of active renin secretion [24]. However,
electron microscopy confirmed that the As4.1 cells used in this
study clearly contain dense core secretory granules, which rules
out the lack of granules as a possible explanation for the inability
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Fig. 4. Secretion of active renin in nontransfected
and and Ren-2 transfected As4. 1 cells. Active
and total renin in the supernatants of As4.1
cells stably transfected with either pCEP4 or a
mouse Ren-2 expression plasmid (see
Methods). After washing, supernatants were
collected from the cells after five minutes of
incubation. Values are expressed as ng Ang TI
hr4g DNA, and correspond to mean SD
(N = 6). A. Secretion of active renin. < 0.05
versus cells transfected with the control pCEP4
plasmid; < 0.05 versus cells incubated in
the absence of forskolin (as determined by one-
way ANOVA followed by Neuman-Keul's post-
hoc test). U. Secretion of total renin. Forskolin
had no effect on total renin secretion. Symbols
are: (U) control; (LI) forskolin.
of As4.l cells to secrete active renin-1 via the regulated pathway.
Furthermore, transfection of As 4.1 cells with an expression
plasmid for mouse Ren-2 showed that the cell line had conserved
the ability to process Ren-2 and to release it via the regulated
pathway (Fig. 4).
The defect in secretion of active renin by As4.1 cells might be
more readily explained (at least in part) by the loss of expression
of the necessary processing enzyme within the regulated pathway.
A family of mammalian proteases involved in the processing of
protein and peptide precursors has recently been identified as
prohormone/proprotein convertases (PCs) [reviewed in 25]. As
some of these (PCi, PC5) have been shown to be capable of
activating human prorenin and/or mouse Ren-2 prorenin [10, 11,
26], we sought to determine which of these particular processing
enzymes are produced by As4.1 cells. Northern blot and RT-PCR
analysis revealed that furin, PACE4 and PC5 were the only
convertases expressed in these cells, and PC5 is the only one
among these that has been shown to be capable of activating some
forms of prorenin [11, 26]. Since As 4.1 cells do not secrete any
significant amounts of active Ren-1, it is unlikely that Ren-1 could
be activated by PC5 within the regulated pathway. However, one
can postulate that expression of PCs found in As4.1 cells would be
retained in the juxtaglomerular cells of mice expressing both renin
genes, and may also be retained in the juxtaglomerular cells of
other species such as rats and humans. It has been shown
previously that PC5 could process mouse Ren-2 [26], and our own
data show that As 4.1 can process Ren-2 when it is transfected in
these cells (Fig. 4). As most strains of mice express both Rcn-1
and Ren-2 in the JG cells of the kidney, it is quite probable that
PC5 would contribute to the secretion of active renin from the JG
cells in these strains. Likewise, PCS can activate human prorenin,
and has recently been proposed as a candidate processing enzyme
of prorenin in the human adrenal gland [11]. PC5 is expressed in
many endocrine tissues [27], although its expression does not
appear to be distributed as widely as other convertases [18]. Taken
together, these data indicate that PC5 is a candidate enzyme for
the processing of mouse Ren-2 and human renin (either in
kidneys or other tissues), but that the enzyme that processes
prorenin-1 in mouse JG cells may be another, as yet undefined
member of the PC gene family.
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